{
  "abstract": "An optimal nucleic acid delivery system for hepatic therapeutics should demonstrate consistent pharmacological performance across both normal and diseased hepatic microenvironments, enabling repeated administration with favorable safety profiles. Given the disease-sensitive and relatively low expression of low-density lipoprotein receptor (LDLR) on hepatocytes and compared to the abundant and disease-resilient expression of asialoglycoprotein receptor (ASGPR), ASGPR-mediated drug delivery presents a compelling strategy for liver diseases. Here, we introduce Hepa-SENS, a next-generation polymer-lipid hybrid nanoparticle platform enabling robust ASGPR-mediated hepatocyte delivery without ligand conjugation. Its biodistribution, hepatocyte selectivity, receptor dependence, repeated-dose activity, and therapeutic performance were evaluated in healthy and fibrotic mouse liver models. Hepa-SENS demonstrates strong, hepatocyte-selective transgene expression of mRNA payload preserved under disease conditions, such as high-fatty liver and liver fibrosis, and across multiple species, including non-human primates. In long-term repeat-dose regimens, Hepa-SENS sustained mRNA-driven protein expression without inducing antibodies to the delivery system, enabling greater consistency than conventional lipid nanoparticles (LNPs). In fact, in a liver fibrosis mouse model, where a reduction of LDLR is observed as fibrosis develops, Hepa-SENS outperformed conventional LNPs in delivering therapeutic hepatocyte nuclear factor 4 alpha mRNA and attenuating disease progression. In conclusion, Hepa-SENS represents a robust and versatile delivery platform for nucleic acid therapeutics targeting hepatocytes under disease-relevant conditions via ASGPR-dependent mechanisms. Its repeated-dosing-compatible design supports durable treatment strategies for chronic liver diseases.",
  "abstract_shown": true,
  "affiliations": [
    "Samyang Biopharm Corporation, R&D Center, Seongnam-si, Republic of Korea"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 10,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Goo-Young Kim"
    },
    {
      "affs": [
        0
      ],
      "name": "Sojin Lee"
    },
    {
      "affs": [
        0
      ],
      "name": "Hyosuk Kim"
    },
    {
      "affs": [
        0
      ],
      "name": "Hyejin Park"
    },
    {
      "affs": [
        0
      ],
      "name": "Yisak Kim"
    },
    {
      "affs": [
        0
      ],
      "name": "Jihye Choi"
    },
    {
      "affs": [
        0
      ],
      "name": "Jongmin Kim"
    },
    {
      "affs": [
        0
      ],
      "name": "Jongmin Park"
    },
    {
      "affs": [
        0
      ],
      "name": "Joungpyo Nam"
    },
    {
      "affs": [
        0
      ],
      "name": "Helen Cho"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/ez2932x36bw2v.bib",
  "cited_by": 0,
  "doi": "10.1080/10717544.2026.2752664",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13757799/",
  "id": "ez2932x36bw2v",
  "issns": [
    "1071-7544",
    "1521-0464"
  ],
  "landing_url": "https://doi.org/10.1080/10717544.2026.2752664",
  "language": "en",
  "licence": "CC-BY-NC-4.0",
  "licence_label": "CC BY-NC 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Research Article"
    ],
    [
      "openalex",
      "1312|RNA Interference and Gene Delivery"
    ]
  ],
  "openalex": "W7225250265",
  "pdf_url": "https://www.tandfonline.com/doi/pdf/10.1080/10717544.2026.2752664?needAccess=true",
  "pmcid": "PMC13757799",
  "pmid": "42978531",
  "published": "2026-11-04",
  "publisher": "Taylor & Francis",
  "ris": "https://research.draconitic.com/paper/ez2932x36bw2v.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:23:22Z",
      "native_id": "PMC13757799",
      "source": "pmc",
      "url": "https://doi.org/10.1080/10717544.2026.2752664"
    }
  ],
  "subjects": [
    {
      "field": "biochemistry",
      "origin": "openalex:1312|RNA Interference and Gene Delivery",
      "subfield": "molecular-biology"
    }
  ],
  "title": "Hepa-SENS: ASGPR-mediated hepatocyte delivery and attenuated unwanted immune recognition for nucleic acid therapeutics",
  "title_text": "Hepa-SENS: ASGPR-mediated hepatocyte delivery and attenuated unwanted immune recognition for nucleic acid therapeutics",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:23:22Z",
  "url": "https://research.draconitic.com/paper/ez2932x36bw2v",
  "venue": "Drug Delivery",
  "versions": []
}